The RNA Polymerase “Switch Region” Is a Target for Inhibitors

The alpha-pyrone antibiotic myxopyronin (Myx) inhibits bacterial RNA polymerase (RNAP). Here, through a combination of genetic, biochemical, and structural approaches, we show that Myx interacts with the RNAP "switch region"--the hinge that mediates opening and closing of the RNAP active center cleft--to prevent interaction of RNAP with promoter DNA. We define the contacts between Myx and RNAP and the effects of Myx on RNAP conformation and propose that Myx functions by interfering with opening of the RNAP active-center cleft during transcription initiation. We further show that the structurally related alpha-pyrone antibiotic corallopyronin (Cor) and the structurally unrelated macrocyclic-lactone antibiotic ripostatin (Rip) function analogously to Myx. The RNAP switch region is distant from targets of previously characterized RNAP inhibitors, and, correspondingly, Myx, Cor, and Rip do not exhibit crossresistance with previously characterized RNAP inhibitors. The RNAP switch region is an attractive target for identification of new broad-spectrum antibacterial therapeutic agents.

[1]  J. Roberts,et al.  Promoter recognition as measured by binding of polymerase to nontemplate strand oligonucleotide. , 1997, Science.

[2]  T. Steitz,et al.  Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. , 1992, Science.

[3]  S. Webber,et al.  Myxopyronin B analogs as inhibitors of RNA polymerase, synthesis and biological evaluation. , 2004, Bioorganic & medicinal chemistry letters.

[4]  I. Chopra,et al.  Bacterial RNA polymerase: a promising target for the discovery of new antimicrobial agents. , 2007, Current opinion in investigational drugs.

[5]  H. Reichenbach,et al.  Antibiotics from Gliding Bacteria, LXXVIII†. Ripostatin A, B, and C: Isolation and Structure and Structure Elucidation of Novel Metabolites from Sorangium cellulosum , 1996 .

[6]  K. Murakami,et al.  Structural Basis of Transcription Initiation: RNA Polymerase Holoenzyme at 4 Å Resolution , 2002, Science.

[7]  M. A. Wuonola,et al.  Total Synthesis and Preliminary Antibacterial Evaluation of the RNA Polymerase Inhibitors (±)-Myxopyronin A and B , 1998 .

[8]  H. Reichenbach,et al.  The ripostatins, novel inhibitors of eubacterial RNA polymerase isolated from myxobacteria. , 1995, The Journal of antibiotics.

[9]  Younggyu Kim,et al.  Structural Organization of the RNA Polymerase-Promoter Open Complex , 2000, Cell.

[10]  Patrick Cramer,et al.  Multisubunit RNA polymerases. , 2002, Current opinion in structural biology.

[11]  Arkady Mustaev,et al.  Structural Mechanism for Rifampicin Inhibition of Bacterial RNA Polymerase , 2001, Cell.

[12]  P. Cramer,et al.  Structural Basis of Transcription: RNA Polymerase II at 2.8 Ångstrom Resolution , 2001, Science.

[13]  Jianping Ding,et al.  Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance. , 1994, Journal of molecular biology.

[14]  Jennifer L. Knight,et al.  Antibacterial peptide microcin J25 inhibits transcription by binding within and obstructing the RNA polymerase secondary channel. , 2004, Molecular cell.

[15]  E. Kool,et al.  Generation of catalytic RNAs by rolling transcription of synthetic DNA nanocircles , 1997, Nature Biotechnology.

[16]  M. Chamberlin,et al.  Studies of in vitro transcription by calf thymus RNA polymerase II using a novel duplex DNA template. , 1982, The Journal of biological chemistry.

[17]  R. Ebright.  RNA polymerase: structural similarities between bacterial RNA polymerase and eukaryotic RNA polymerase II. , 2000, Journal of molecular biology.

[18]  S. Darst,et al.  Bacterial RNA polymerase. , 2001, Current opinion in structural biology.

[19]  S. Darst,et al.  New inhibitors targeting bacterial RNA polymerase. , 2004, Trends in biochemical sciences.

[20]  H. Reichenbach,et al.  ANTIBIOTICS FROM GLIDING BACTERIA. XVII. MYXOPYRONIN A AND B - TWO NOVEL ANTIBIOTICS FROM MYXOCOCCUS FULVUS STRAIN MX F50 , 1984 .

[21]  C. Fishwick,et al.  RNA Polymerase Inhibitors with Activity against Rifampin-Resistant Mutants of Staphylococcus aureus , 2000, Antimicrobial Agents and Chemotherapy.

[22]  S. Webber,et al.  Syntheses of novel myxopyronin B analogs as potential inhibitors of bacterial RNA polymerase. , 2007, Bioorganic & medicinal chemistry letters.

[23]  Ivet Bahar,et al.  Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding. , 2004, Current HIV research.

[24]  P. Dehaseth,et al.  Protein-nucleic acid interactions during open complex formation investigated by systematic alteration of the protein and DNA binding partners. , 1999, Biochemistry.

[25]  S. Yokoyama,et al.  Crystal structure of a bacterial RNA polymerase holoenzyme at 2.6 Å resolution , 2002, Nature.

[26]  H. Reichenbach,et al.  The myxopyronins, new inhibitors of bacterial RNA synthesis from Myxococcus fulvus (Myxobacterales). , 1983, The Journal of antibiotics.

[27]  H. Reichenbach,et al.  Antibiotika aus Gleitenden Bakterien, XXIV. Corallopyronin A, B und C – drei neue Antibiotika aus Corallococcus coralloides Cc c127 (Myxobacterales) , 1985 .

[28]  Tahir H. Tahirov,et al.  Structural basis for transcription elongation by bacterial RNA polymerase , 2007, Nature.

[29]  F. Neidhart.  Escherichia coli and Salmonella. , 1996 .

[30]  K. Murakami,et al.  Structural Basis of Transcription Initiation: An RNA Polymerase Holoenzyme-DNA Complex , 2002, Science.

[31]  H. Reichenbach,et al.  The corallopyronins, new inhibitors of bacterial RNA synthesis from Myxobacteria. , 1985, The Journal of antibiotics.

[32]  H. Reichenbach,et al.  Antibiotika aus Gleitenden Bakterien. XVII: Myxopyronin A und B ― zwei neue Antibiotika aus Myxococcus fulvus Stamm Mx f50 , 1983 .

[33]  J. Gralla,et al.  Promoter opening via a DNA fork junction binding activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  K. Murakami,et al.  Bacterial RNA polymerases: the wholo story. , 2003, Current opinion in structural biology.

[35]  C. Gross,et al.  Views of Transcription Initiation , 2002, Cell.

[36]  P. Cramer,et al.  Structural Basis of Transcription: An RNA Polymerase II Elongation Complex at 3.3 Å Resolution , 2001, Science.

[37]  A. D. Clark,et al.  Inhibition of Bacterial RNA Polymerase by Streptolydigin: Stabilization of a Straight-Bridge-Helix Active-Center Conformation , 2005, Cell.

[38]  K. Severinov,et al.  Crystal Structure of Thermus aquaticus Core RNA Polymerase at 3.3 Å Resolution , 1999, Cell.